Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Dimitrov Website

Dimiter S. Dimitrov, Ph.D.

Selected Publications

1)  Tang Z, Feng M, Gao W, Phung Y, Chen W, Chaudhary A, Croix BS, Qian M, Dimitrov DS, Ho M.
A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface.
Mol. Cancer Ther. [Epub ahead of print], 2013.
2)  Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ.
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.
Blood. 121: 1165-74, 2013.
3)  Chen W, Ying T, Dimitrov DS.
Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.
Expert Opin Biol Ther. 13: 657-71, 2013.
4)  Zhu Z, Prabakaran P, Chen W, Broder CC, Gong R, Dimitrov DS.
Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1.
Virol Sin. 28: 71-80, 2013.
5)  Meyerson JR, Tran EE, Kuybeda O, Chen W, Dimitrov DS, Gorlani A, Verrips T, Lifson JD, Subramaniam S.
Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives.
Proc. Natl. Acad. Sci. U.S.A. 110: 513-8, 2013.
6)  Feng M, Gao W, Wang R, Chen W, Man YG, Figg WD, Wang XW, Dimitrov DS, Ho M.
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma.
Proc. Natl. Acad. Sci. U.S.A. 110: E1083-91, 2013.
7)  Feng Y, Dimitrov DS.
Antibody-based therapeutics against components of the IGF system.
Oncoimmunology. 1: 1390-1391, 2012.
8)  Gong R, Wang Y, Ying T, Dimitrov DS.
Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn.
PLoS ONE. 7: e42288, 2012.
9)  Gong R, Chen W, Dimitrov DS.
Candidate Antibody-Based Therapeutics Against HIV-1.
BioDrugs. 26: 143-62, 2012.
10)  Varewijck AJ, Brugts MP, Frystyk J, Goudzwaard JA, Uitterlinden P, Waaijers AM, Feng Y, Dimitrov DS, Lamberts SW, Hofland LJ, Janssen JA.
Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.
Mol. Cell. Endocrinol. [Epub ahead of print], 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 4/22/2013.